Microbot Medical announced it has entered into an agreement with Emory University, which will allow the parties to evaluate and explore the potential for a future collaboration in connection with autonomous robotics in endovascular procedures. Under the terms of the agreement, Emory University will assume the responsibility of exploring the feasibility of integrating the LIBERTY Endovascular Robotic Surgical System with an imaging system to create an autonomous robotic system for endovascular procedures. Amir Pourmorteza, PhD, Assistant Professor in the Department of Radiology and Imaging Sciences at Emory University Winship Cancer Institute, and Department of Biomedical Engineering at Georgia Institute of Technology, will lead the evaluation under Project Trita.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBOT:
- Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
- Microbot Medical Advances in Clinical Trials and FDA Process
- Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
- Microbot Medical completes enrollment of sites in human clinical trial
- Microbot Medical Marks Clinical Milestone, Eyes FDA Submission